Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are a class of newly introduced antidiabetic drugs with potent hypoglycemic effects. Recent evidence suggests that these drugs have extraglycemic impacts and are therefore able to provide additional benefits beyond glucose lowering. Mitochondrial d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaribeygi, Habib, Maleki, Mina, Butler, Alexandra E., Jamialahmadi, Tannaz, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939776/
https://www.ncbi.nlm.nih.gov/pubmed/36814854
http://dx.doi.org/10.17179/excli2022-5482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939776/
https://www.ncbi.nlm.nih.gov/pubmed/36814854
http://dx.doi.org/10.17179/excli2022-5482

Ejemplares similares